"0173-0821-33" National Drug Code (NDC)

Arzerra 3 VIAL in 1 CARTON (0173-0821-33) > 5 mL in 1 VIAL (0173-0821-02)
(GlaxoSmithKline LLC)

NDC Code0173-0821-33
Package Description3 VIAL in 1 CARTON (0173-0821-33) > 5 mL in 1 VIAL (0173-0821-02)
Product NDC0173-0821
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameArzerra
Non-Proprietary NameOfatumumab
Dosage FormINJECTION, SOLUTION
UsageINTRAVENOUS
Start Marketing Date20110722
End Marketing Date20170831
Marketing Category NameBLA
Application NumberBLA125326
ManufacturerGlaxoSmithKline LLC
Substance NameOFATUMUMAB
Strength20
Strength Unitmg/mL
Pharmacy ClassesCD20-directed Cytolytic Antibody [EPC],CD20-directed Antibody Interactions [MoA]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/0173-0821-33